TITLE:
      Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
SUMMARY:
      This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption
      and crime-related post-traumatic stress disorder in those individuals with both disorders.
      This will be a 12-week, placebo-controlled, double-blind outpatient trial.

      All subjects will receive cognitive behavioral therapy in addition to a placebo or
      sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and
      6, 9, and 12 months after study entry.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Meets criteria for alcohol abuse or dependence and post-traumatic stress disorder.

          -  Laboratory tests for blood and urinalysis must be within normal limits.

          -  Must be clearly motivated to obtain benefit from treatment and keep appointments for
             study visits and therapy sessions.

          -  Females who use an acceptable method of birth control, are sterilized, or are at
             least 2 years post-menopausal.

        Exclusion Criteria:

          -  Have a diagnosis of schizophrenia, bipolar affective disorder, dissociative identity
             disorder, eating disorder, substance dependence in the last 60 days.

          -  Currently suicidal.

          -  Medical reasons not to receive drug therapy.

          -  Allergy or hypersensitivity to selective serotonin inhibitor antidepressants.

          -  Significant hematological, endocrine, cardiovascular, renal, hepatic, neurological,
             or gastrointestinal disease.

          -  Liver function test greater than 2 times the normal level

          -  Require ongoing therapy with another psychoactive drug during the study period.

          -  Females who are pregnant or lactating.
